Fecal immunochemical test screening for colon and rectal cancer
Menée en Italie à partir de données portant sur 123 347 personnes âgées de 50 à 69 ans ayant participé entre 2002 et 2014 à six sessions d'un programme de dépistage du cancer colorectal comportant un test immunochimique de recherche de sang occulte dans les selles (FIT), cette étude évalue, en fonction de la localisation (côlon proximal, côlon distal ou rectum) et du point de vue des taux de détection d'adénomes de stade avancé et de lésions cancéreuses, l'efficacité du test FIT
What is the problem and what is known about it so far ?
Several studies have shown that screening mature adults for colon and rectal cancer saves lives and preserves health. There are several ways to screen, and different people prefer different types of screening. Many people prefer the FIT (fecal immunochemical test). This test does not require inserting a tube into the rectum, and the sample can be collected at home. Previous studies suggest that this test is better at detecting cancer in the colon when it is closer to the rectum than when it is farther from the rectum.
Annals of Internal Medicine , article en libre accès, 2017